Suppr超能文献

通过类固醇注射解冻肩周炎

Thawing frozen shoulder by steroid injection.

作者信息

Pushpasekaran Narendran, Kumar Narender, Chopra R K, Borah Diganta, Arora Sumit

机构信息

1 Department of orthopaedics, Maulana Azad Medical College & Lok Nayak Hospital, New Delhi, India.

2 Department of orthopaedics. Central Institute of Orthopaedics, V.M.M.C & Safdarjang Hospital, New Delhi, India.

出版信息

J Orthop Surg (Hong Kong). 2017 Jan;25(1):2309499016684470. doi: 10.1177/2309499016684470.

Abstract

BACKGROUND

Frozen shoulder is not an uncommon disorder, and steroid injection into the glenohumeral (GH) joint is one of the most well-known approaches for the frozen shoulder. However, their results have been varied with beneficial effects or no additional advantage. With the understanding about the pathological changes taking place in frozen shoulder and the biomechanics involved, we wanted to evaluate the short- and long-term efficacy of steroid injection by a novel three-site (NTS) injection technique and compare it with the single-site injection (SSI).

MATERIAL AND METHODS

This was a prospective study with 85 patients including all stages and randomized into two groups. SSI group received steroid injection through posterior approach. NTS group received the same dose of steroid in diluted doses at three sites (posterior capsule, subacromial and subcoracoid). Second sitting was repeated after 3 weeks. Both groups had received the same physiotherapy. The patients were evaluated by CONSTANT score at initial, 3 week, 6 week and 6 month.

RESULTS

NTS group patients had significant pain relief and early improvement in activities of daily living ( p < 0.005). Both groups had improvement in shoulder movements but with NTS group, early near-normal scores were attained and sustained after 6 months. About 43% in SSI group could not attain near-normal levels and had relapses.

CONCLUSION

The three-site approach to steroid instillation in frozen shoulder is a safe method and provides early recovery and better improvement in shoulder function with less relapses.

摘要

背景

肩周炎并不罕见,向盂肱(GH)关节注射类固醇是治疗肩周炎最广为人知的方法之一。然而,其结果各不相同,有的有有益效果,有的则无额外优势。基于对肩周炎病理变化及相关生物力学的了解,我们想评估一种新型三点注射(NTS)技术进行类固醇注射的短期和长期疗效,并将其与单点注射(SSI)进行比较。

材料与方法

这是一项前瞻性研究,纳入85例各阶段患者并随机分为两组。SSI组通过后路进行类固醇注射。NTS组在三个部位(后关节囊、肩峰下和喙突下)注射相同剂量稀释后的类固醇。3周后重复第二次注射。两组接受相同的物理治疗。在初始、3周、6周和6个月时通过CONSTANT评分对患者进行评估。

结果

NTS组患者疼痛明显缓解,日常生活活动能力早期得到改善(p < 0.005)。两组肩部活动均有改善,但NTS组在6个月后早期达到并维持接近正常的评分。SSI组约43%的患者未达到接近正常水平且出现复发。

结论

肩周炎类固醇注射的三点法是一种安全的方法,能实现早期恢复,更好地改善肩部功能,且复发较少。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验